General anaesthesia with aerosol box during COVID pandemic

Not Applicable

Completed

• Conditions: Health Condition 1: C00-D49- Neoplasms

• Registration Number: CTRI/2020/07/026610
• Lead Sponsor: Cancer Institute WIA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-09-04
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 136

Inclusion Criteria

1.Age: Patients of both sexes greater than or equal to 18 yrs of age

2.Patients receiving suxamethonium or rocuronium (if allergic to suxamethonium or contraindication to suxamethonium) will be included.

3.Intubations performed by anaesthesiologists who have � 3 years clinical experience following their training will be considered for the study.

4.Anaesthesiologists will use the conventional Macintosh Laryngoscope or the C-Mac Video Laryngoscope depending upon the availability and comfort.

Exclusion Criteria

1.Patients requiring awake fiberoptic guided intubation.

2.Patients who cannot fit within the aerosol box due to their body habitus.

3.Patients who are undergoing emergency surgery and are at risk for gastric aspiration.

4.Patients requiring double lumen tube (DLT) insertion

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to intubation- defined as time from when the laryngoscope blade passes between the patients lips until the first upstroke of the capnograph traceTimepoint: 24 hours

Secondary Outcome Measures

Name	Time	Method
1.Airway manipulation time <br/ ><br>2.The number of attempts made to intubate. <br/ ><br>3.First pass success rate <br/ ><br>4.Fall in saturation during the period of intubation to SpO2� 90%. <br/ ><br>5.Failure to intubate using aerosol boxTimepoint: 24 hours